- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01830738
Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique (HOT)
Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique : a Prospective, Randomized, Multicenter Study Evaluating the Length of Hospital Stay
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The secondary objectives are to compare the following between the two arms of the study:
- the difference between the real discharge date and the theoretical discharge date
- measures related to intraoperative bleeding
- operating time
- postoperative pain
- quality of life
- abdominal wall complication rates
- rates of further surgery and rehospitalization
- use of material resources in the operating room
- average costs of hospital stay
- Costs of rehospitalization at 1 year
- Indirect costs
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13385
- APHM - Hôpital de la Conception
-
Nîmes Cedex 9, France, 30029
- CHU de Nimes - Hopital Universitaire Caremeau
-
Saint-Priest en Jarez, France, 42270
- CHU de Saint Etienne - Hopital Nord
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient must have given her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is available for 12 months of follow-up
- The patient is declared fit by the anesthetist for an intervention by laparoscopy
Exclusion Criteria:
- The patient is not available for 12 months of follow-up
- The patient is participating in another study or is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient is not insured or beneficiary of a health insurance plan
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient cannot read French
- Patient with a history of pelvic radiotherapy
- Patient with a history of pelvic surgery or serious risk of major adhesions
- The patient is pregnant
- Contraindications for anesthesia for either surgical technique
- Promontofixation or lymphadenectomy
- No associated procedure other than morcellation or vaginal suture for extracting the hysterectomy specimen, unilateral or bilateral oophorectomy
- The patient has a known or suspected allergy to polyurethane
- Extended hysterectomy for neoplastic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Peri-umbilical single-port
Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique. Intervention: Single-port, peri-umbilical hysterectomy |
Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique.
|
|
Active Comparator: Multi-port
Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique. Intervention: Multi-port hysterectomy |
Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Length of hospital stay in hours
Time Frame: Maximum 1 month (usually 3 to 5 days)
|
Maximum 1 month (usually 3 to 5 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in hours between real discharge time and theoretical discharge time
Time Frame: 4 weeks
|
Criteria for theoretical hospital discharge:
|
4 weeks
|
|
Bleeding/fluid loss: Difference between lavage fluids and aspiration fluids
Time Frame: Day 0 (during surgery)
|
Day 0 (during surgery)
|
|
|
Change in hemoglobin measure
Time Frame: Day 3 versus baseline
|
Day 3 versus baseline
|
|
|
Change in hematocrit measure
Time Frame: Day 3 versus baseline
|
Day 3 versus baseline
|
|
|
Surgical time, from first incision to closing
Time Frame: Day 0 (during surgery)
|
Day 0 (during surgery)
|
|
|
Visual analog scale for pain
Time Frame: 2 hours after end of surgery (Day 0)
|
2 hours after end of surgery (Day 0)
|
|
|
Visual analog scale for pain
Time Frame: 3 times per day during hospitalisation (expected maximum of 3 to 5 days)
|
3 times per day during hospitalisation (expected maximum of 3 to 5 days)
|
|
|
Questionnaire SF 36
Time Frame: baseline
|
Quality of Life
|
baseline
|
|
Questionnaire SF 36
Time Frame: 4 weeks
|
Quality of Life
|
4 weeks
|
|
Complication rate
Time Frame: Day 1
|
Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation
|
Day 1
|
|
Complication rate
Time Frame: 4 weeks
|
Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation
|
4 weeks
|
|
Complication rate
Time Frame: 12 months
|
Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation
|
12 months
|
|
Re-intervention/hospitalisation rate
Time Frame: 12 months
|
12 months
|
|
|
Surgical conversion rate
Time Frame: Day 0 (during surgery)
|
Day 0 (during surgery)
|
|
|
Trocar site infection rate
Time Frame: 4 weeks
|
4 weeks
|
|
|
Presence/absence of complications according to Clavien scale
Time Frame: Day 1
|
Day 1
|
|
|
Presence/absence of complications according to Clavien scale
Time Frame: 12 months
|
12 months
|
|
|
Inventory of reusable material in the operating room and related costs.
Time Frame: Day 0 (after surgery)
|
Day 0 (after surgery)
|
|
|
Estimatin of indirect costs
Time Frame: 4 weeks
|
4 weeks
|
|
|
Estimation of direct costs
Time Frame: 12 months
|
12 months
|
|
|
Questionnaire SF 36
Time Frame: 12 months
|
Quality of Life
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LOCAL/2012/VL-03
- 2012-A01054-36 (Other Identifier: RCB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Hitit UniversityErol Olcok Corum Training and Research HospitalCompletedHysterectomy (MeSH nr: E04.950.300.399) | Had Undergone a Hysterectomy | Had Not Been Diagnosed With Cancer | After HysterectomyTurkey (Türkiye)
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruiting
-
Medical University of South CarolinaRecruiting
-
Memic Innovative SurgeryRecruiting
-
Universita di VeronaCompleted
-
Indiana UniversityCompleted
Clinical Trials on Single-port, peri-umbilical hysterectomy
-
The Catholic University of KoreaCompletedPostoperative Pain | Uterine Disease
-
Hospital General Universitario ElcheUnknownIncisional HerniaMexico, Spain
-
Chang Gung Memorial HospitalCompleted
-
Herning HospitalWithdrawnPain | Wound | Activity, MotorDenmark
-
Asan Medical CenterCompletedBenign or Preinvasive Uterine DiseaseKorea, Republic of
-
Rambam Health Care CampusCompletedPelvic Organ ProlapseIsrael
-
Hospital Authority, Hong KongUnknown
-
Samsung Medical CenterUnknownUterine Adenomyosis | Uterine MyomaKorea, Republic of
-
Hung Vuong HospitalNot yet recruitingEctopic Pregnancy
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityUnknown